Sports Medicine: Just the Facts

(やまだぃちぅ) #1
20%. The test is concluded but considered negative if
the maximum solution concentration of 25 mg/mL is
administered without the diagnostic drop in FEV1
(Eliasson, Phillips, and Rajagopal, 1992).


  • Albuterol may be given 3 min after a positive test to
    demonstrate airway bronchospasm reversibility that is
    consistent with asthma.


EUCAPNIC VOLUNTARY HYPERVENTILLATION
(EVH) TEST



  • Used by the International Olympic Committee-
    Medical Committee (IOC-MC) to verify EIA and the
    need for precompetition beta agonist (Anderson et al,
    2003).

  • Sensitivity in athletes has been shown to be 50% sen-
    sitive and up to 100% specific (Eliasson, Phillips, and
    Rajagopal, 1992).

  • EVH is a well-known and accepted provocative test
    for EIA (Holzer, 2002; Mannix, Manfredi, and Farber,
    1999).

  • This test is more sensitive than an exercise challenge
    in the field or in the lab (Holzer, 2002; Mannix,
    Manfredi, and Farber, 1999).

  • EVH is more sensitive than methacholine in response
    to dry air hyperpnea (Holzer, 2002).


CONDUCTING THEEVH TEST



  • Obtain a baseline PFT. Record the best FEV1.
    •Argyros and colleagues (Anderson et al, 2001;
    Argyros et al, 1995) protocol based on single-level
    ventilation of 85% of the maximum voluntary venti-
    lation (MVV) is used. MVV is calculated as 35
    times the best recorded pretest FEV1 and is used to
    calculate the volume of dry gas ventilated per
    minute.

  • The athlete inhales dry gas consisting of 5% carbon
    dioxide, 21% oxygen, and the remainder nitrogen gas.
    The volume of ventilated gas is measured by a
    metered instrument. The athlete gauges and adjusts
    the rate of ventilation based on the volume of dry gas
    ventilated.

  • The athlete breaths at a rate of 85% MVV for 6 min.

  • At the completion of the 6 min the FEV1 is measured
    twice at 1, 3, 5, 7, and 8 min post challenge. The best
    FEV1 value is used.
    •A drop in FEV1 of at least 20% is diagnostic for EIA
    (Holzer, 2002).
    •A bronchodialator may be administered at the conclu-
    sion of the study to decrease the patient’s symptoms
    and document reversibility of airway hyperresponsive-
    ness.


EVALUATING ATHLETES WITH
SUSPECTED EIA


  • The most appropriate provocative test for identifying
    EIA remains controversial (Rundell et al, 2001;
    Anderson et al, 2001; Eliasson, 1999).

  • EVH may be the preferred method of laboratory
    provocative testing because of its relative ease and
    excellent sensitivity. It is also more sensitive than an
    exercise challenge in a lab or field environment
    (Holzer, 2002; Mannix, Manfredi, and Farber, 1999).
    EVH provocative testing is the preferred diagnostic
    study of the IOC-MC.

  • If EVH testing is unavailable, a sport and climate-spe-
    cific exercise challenge is an acceptable alternative. A
    methacholine challenge is also an acceptable option.
    •Avoid empirically treating for EIA without formal
    provocative testing. Classic symptoms alone are unre-
    liable and may lead to over- or underusage of the
    appropriate medical therapy.


REFERENCES


Anderson SD, Argyros GJ, Magnussen H, et al: Provocation
by eucapnic voluntary hyperpnea to identify exercise-
induced bronchoconstriction. Br J Sports Med 35:344–347,
2001.
Anderson SD, Fitch K, Perry CP, et al: Response to bronchial
challenge submitted for approval to use inhaled beta 2 agonists
before an event at the 2002 winter Olympics. J Allergy Clin
Immunol 111(1):45–50, 2003.
Anderson SD, Lambert S, Brannan JD, et al: Laboratory protocol
for exercise asthma to evaluate salbutamol given by two
devices. Med Sci Sports Exerc 33:893–900, 2001.
Argyros GJ, Roach JM, Hurwitz KM, et al: The refractory period
after eucapnic voluntary hyperventilation challenge and its
effect on challenge technique. Chest 108:419–424, 1995.
Avital A: Exercise, methacholine, and adenosine 5’ monophos-
phate challenges in children with asthma: relation to
decreased severity of disease. Pediatr Pulmonol
30(3):207–214, 2000.
Brennan Fred H, Jr: Exercise-induced asthma testing, in
O’Connor FG, Wilder R (eds.): Textbook of Running Medicine.
New York, NY, McGraw-Hill, 2001, p 101–107.
Eliasson AH: Blow dry your asthma. Chest115:608–609, 1999.
Eliasson AH, Phillips YY, Rajagopal KR: Sensitivity and speci-
ficity of bronchial provocation testing. An evaluation of four
techniques in exercise-induced bronchospasm. Chest102:347,
1992.
Holzer K: Exercise in elite summer athletes: challenges for diag-
nosis. J Allergy Clin Immunol 110(3):374–380, 2002.
Lin CC, Wu JL, Huang WC, et al: A bronchial response compar-
ison of exercise and methacholine in asthmatic subjects.
J Asthma28:31–35, 1991.

136 SECTION 2 • EVALUATION OF THE INJURED ATHLETE

Free download pdf